SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
GKOS

GLAUKOS Corp (New York Stock Exchange:GKOS)

US · Delayed Price · Currency is USD
Healthcare · Medical - Devices
$237.31-$0.79 (-0.33%)
 
Market cap
$14.0B
Insider Score
Health Score
Analyst consensus
Listed since
Jun 25, 2015
Market Cap$14.05B+138.2%
Revenue (ttm)$690.33M+46.9%
Net Income-$169.80M-93.8%
EPS-$2.94-90.9%
Shares Out59.20M
PE Ration/a
Forward PE169.47
Dividendn/a
Ex-Dividend Daten/a
Volume1,089,555
Open$237.34
Previous Close$238.10
Day's Range$233.27 - $244.48
52-Week Range$93.96 - $255.19
Beta0.69
AnalystsBuy
Price Target$225.55(-4.96%)
Earnings DateFeb 16, 2027

About GKOS

Glaukos Corporation operates as an ophthalmic medical technology and pharmaceutical enterprise, primarily focused on pioneering novel therapies for glaucoma, corneal disorders, and retinal diseases. The company offers a range of micro-bypass stents, including iStent, iStent inject, and iStent inject W. These devices are designed to enhance aqueous humor outflow, being inserted during cataract surgery to treat mild-to-moderate open-angle glaucoma. Its promising product pipeline features iStent Infinite, a three-stent system intended for standalone use in patients with refractory glaucoma, as well as iDose TR, a targeted injectable implant that utilizes Glaukos's micro-scale device platform to deliver therapeutic levels of medication. The company distributes its products through a direct sales organization and a network of distributors, serving markets across the United States and internationally. Glaukos Corporation, founded in 1998, is headquartered in San Clemente, California.

Address
One Glaukos Way, Aliso Viejo, CA, 92656, US
Market Cap
14.05 billion
Employees
1,094
Industrial Classification
Medical - Devices

What Are Insiders Doing?

Open-market buy / sell balanceNet Selling
Sold
$46.10M
Bought
$0

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

Analyst consensus

Moderate Buy
10 Buy0 Hold0 SellAvg target $234.25 (-1.3%)

10 firms rating GKOS in the last 3 months, one vote each. Issuer-paid research is not counted.

Financial Health Score
Sound
From GKOS’s reported statements · Q3 2026 (trailing 12 months)

Next catalysts

1 Day
-0.33%
5 Days
-3.31%
1 Month
+34.19%
6 Months
+70.69%
1 Year
+138.22%

$GKOS stock is featured in our Insider Score Rankings, and Insider Trades datasets.

→ All Stock Lists

Recently reported changes in GKOS holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by GKOS's directors and management

Net Shares Purchased by Insiders−200k−100k02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

GKOS Estimated quarterly lobbying spending

Source: U.S. Senate LDA

GKOS Revenue by Segment or Geography

$211.03MTotal
Glaucoma$151.99M72.02%
Corneal Health$59.04M27.98%

As of: Q3 2026 (Sep 30, 2026) · Source: SEC EDGAR (10-Q)

U.S. Patents

New GKOS patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to GKOS from public contracts

Source: USAspending.gov

Top ETF Holders

ETFs with the largest estimated holdings in GKOS

IJHiShares Core S&P Mid-Cap ETF$506.09M
IWMiShares Russell 2000 ETF$359.95M
VTIVanguard Morningstar Total Stock Market ETF$333.51M
VBVanguard Morningstar Small-Cap ETF$298.48M
VBKVanguard Morningstar Small-Cap Growth ETF$167.09M
VXFVanguard Extended Market ETF$159.02M

Estimated from each fund’s disclosed top holdings × AUM

Bull Case vs Bear Case

AI-generated from GKOS’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
48% of score
0
Analyst Ratings
32% of score
91
News & Sentiment
20% of score
72

News check: Positive valuation thesis and ETF accumulation activity outweigh single passive selling note; contrarian analyst vindication suggests bullish re-rating potential.

Recent Insider Activity

Buys
0
Sells
26
Buy Value
$0
Distinct Buyers
0

Insider Score Trend Over Time

-35.0 since Aug 21
0255075100Aug 21 — Insider Score 35.0Aug 22 — Insider Score 35.0Aug 23 — Insider Score 35.0Aug 24 — Insider Score 35.0Aug 25 — Insider Score 35.0Aug 26 — Insider Score 35.0Aug 27 — Insider Score 35.0Aug 28 — Insider Score 35.0Aug 29 — Insider Score 35.0Aug 30 — Insider Score 35.0Aug 31 — Insider Score 35.0Sep 1 — Insider Score 0.0Sep 2 — Insider Score 0.0Sep 3 — Insider Score 0.0Sep 4 — Insider Score 0.0Sep 5 — Insider Score 0.0Sep 6 — Insider Score 0.0Sep 7 — Insider Score 0.0Sep 8 — Insider Score 0.0Sep 9 — Insider Score 0.0Sep 10 — Insider Score 0.0Sep 11 — Insider Score 0.0Sep 12 — Insider Score 0.0Sep 13 — Insider Score 0.0Sep 14 — Insider Score 0.0Sep 15 — Insider Score 0.0Sep 16 — Insider Score 0.0Sep 17 — Insider Score 0.0Sep 18 — Insider Score 0.0Sep 19 — Insider Score 0.0Sep 20 — Insider Score 0.0Sep 21 — Insider Score 0.0Sep 22 — Insider Score 0.0Sep 23 — Insider Score 0.0Sep 24 — Insider Score 0.0Sep 25 — Insider Score 0.0Sep 26 — Insider Score 0.0Sep 27 — Insider Score 0.0Sep 28 — Insider Score 0.0Sep 29 — Insider Score 0.0Sep 30 — Insider Score 0.0Oct 1 — Insider Score 0.0Oct 2 — Insider Score 32.0Oct 3 — Insider Score 0.0Oct 4 — Insider Score 0.0Aug 21Sep 12Oct 4

Composite Insider Score (0–100) recomputed on each scoring run from live SEC Form 4 data.

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.

ETFs that hold this stock

NBDSNeuberger Berman Disrupters ETF5.92%
FCUSPinnacle Focused Opportunities ETF4.56%
SGRTSMART Earnings Growth 30 ETF2.95%
HYPGolden Eagle Dynamic Hypergrowth ETF2.78%
ARWGArcher Growth ETF2.77%
PCSGPolen 5Perspectives Small-Mid Growth ETF2.57%
HTECROBO Global Healthcare Technology and Innovation ETF2.26%
XHEState Street SPDR S&P Health Care Equipment ETF2.08%
GSCGoldman Sachs Small Cap Equity ETF1.81%
IHIiShares U.S. Medical Devices ETF1.80%
SAWSAAM Sawgrass U.S. Small Cap Quality Growth ETF1.73%
CTAGCalamos Timpani Active SMID Growth ETF1.57%

Weight is the stock’s share of each fund’s holdings.